LL/2 In Vitro Protein Expression Analysis Assay (Immunoassays)

CAT#: ITS-1022-YF827
Target Cell Organism: Mouse
Target Cell Alternative Name: LLC1
Target Cell Name: LL/2
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide LL/2-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LL/2
Target Cell Organism
Mouse
Target Cell Background
LL/2 (LLC1) is a cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma.
Target Cell Alternative Name
LLC1
Related Diseases
Lewis Lung Carcinoma
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoassays)
Short Description
LL/2-cell based In Vitro Protein Expression Analysis Assay (Immunoassays)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry